Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis
- 28 February 2003
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 90 (2) , 214-222
- https://doi.org/10.1016/s1081-1206(10)62144-8
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Allergic Rhinitis and Its Impact on AsthmaJournal of Allergy and Clinical Immunology, 2001
- Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of “one linked airway disease”Annals of Allergy, Asthma & Immunology, 2000
- Immunobiology of Asthma and RhinitisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Allergic rhinobronchitis: The asthma–allergic rhinitis linkJournal of Allergy and Clinical Immunology, 1999
- Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapyJournal of Allergy and Clinical Immunology, 1996
- Immediate and Late Inflammatory Responses to Ragweed Antigen Challenge of the Peripheral Airways in Allergic Asthmatics: Cellular, Mediator, and Permeability ChangesAmerican Review of Respiratory Disease, 1991
- Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive childrenJournal of Allergy and Clinical Immunology, 1988
- Release of leukotrienes in patients with bronchial asthmaJournal of Allergy and Clinical Immunology, 1988
- Behavior and Clinical Relevance of Histamine and Leukotrienes C4and B4in Grass Pollen-Induced RhinitisAmerican Review of Respiratory Disease, 1987
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984